Lipid A OM-174 increases the natural killer activity of peripheral blood cells from breast cancer patients

Innate Immunity

Volumn 5, Issue 4, 1999, Pages 189-195

  Reisser, Danièle ^a   Arnould, Laurent ^b   Maynadié, Marc ^b   Belichard, Catherine ^b   Coudert, Bruno ^c   Jeannin, Jean François ^a  

^a Université de Bourgogne   (France)

^b CENTRE GEORGES FRANÇOIS LECLERC   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958184777     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/09680519990050040501     Document Type: Article

References (32)

1. Herberman RB, Ortaldo JR Natural killer cells: their role in defenses against disease. Science 1981; 214: 24-30.
2. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187-376.
3. Brittenden J., Heys SD, Ross J., Eremin O. Natural killer cells and cancer. Cancer 1996; 77: 1226-1243.
4. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990; 76: 2421-2438.
5. Nakagomi H., Petersson M., Magnusson I.et al.Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK-cells of patients with colorectal carcinoma. Cancer Res 1993; 53: 5610-5612.
6. Cunningham-Rundles S., Fillipa DA, Braun DW, Antonelli P., Ashikari H. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph nodes cells in breast cancer in women. J Natl Cancer Inst 1981; 67: 585-590.
7. Kang YH, Carl M., Watson P. Ultrastuctural and functional effects of lipopolysaccharide and interleukin-2 on human NK cells. Scanning Microsc 1988; 2: 1567-1586.
8. Lindemann RA Bacterial activation of human natural killer cells: role of cell surface lipopolysaccharide. Infect Immun 1988; 56: 1301-1308.
9. Miranda D., Puente J., Blanco L., Wolf ME, Mosnaim AD In vitro effect of bacterial lipopolysaccharide on the cytotoxicity of human natural killer cells. Res Commun Mol Pathol Pharmacol 1998; 100: 3-14.
10. Matsumoto N., Aze Y., Akimoto A., Fujita T. Restoration of immune responses in tumor-bearing mice by ONO-4007, an antitumor lipid A derivative. Immunopharmacology 1997; 36:69-78.
11. Ogawa T., Uchida H., Amino K. Immunobiological activities of chemically defined lipid A from lipopolysaccharides of Porphyromonas gingivalis. Microbiology 1994; 140: 1209-1216.
12. Fink PC, Klaproth C., Peter HH Effect of lipopolysaccharides, lipid A and interferon on the cell-mediated cytotoxicity of human leukocytes against K-562 tumor cells. Infection 1984; 12: 322-327.
13. Onier N., Hilpert S., Arnould L., Saint-Giorgio V., Exbrayat JM, Jeannin J-F. Expression of inducible nitric oxide synthase in tumors in relation with their regression induced by a lipid A in rats. Int J Cancer 1999; 81: 755-760.
14. Onier N., Hilpert S., Arnould L.et al.Cure of colon metastasis in rats with the new lipid A OM-174. Apoptosis of tumor cells and immunization of rats. Clin Exp Metastas 1999; In press.
15. Brooks CG, Rees RC, Leach RH High nonspecific reactivity of normal lymphocytes against mycoplasma-infected targets in cytotoxicity assays. Eur J Immunol 1979, 9: 159-165.
16. Brünner KT, Enger HD, Cerottini JC The 51Cr release assay as used for the quantitative measurement of cell-mediated cytolysis in vitro. In: Bloom BR, David JR, ed. In vitro methods in cell-mediated and tumor immunity. New York:Academic Press, 1976; B: 423-428.
17. Kutza J., Murasko DM Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-α. Cell Immunol 1994; 155: 195-204.
18. DeBoer KP, Braun DP, Harris JE Natural cytotoxicity and antibody-dependent cytotoxicity in solid tumor cancer patients: regulation by adherent cells. Clin Immunol Immunopathol 1982; 23: 133-144.
19. Gatti G., Del Ponte D, Cavallo R.et al.Circadian changes in human natural killer activity. Prog Clin Biol Res 1987; 227: 399-409.
20. Salata RA, Kleinhenz ME, Schacter BZ, Ellner JJ Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of non-adherent lymphocytes to tumor targets and tumor killing. Cancer Res 1984; 44: 1044-1047.
21. Hannet I., Erkeller-Yuksel F., Lydyard P., Deneys V., DeBruyère M. Developmental and maturational changes in human blood subpopulations. Immunol Today 1992; 13: 215-218.
22. McNerlan SE, Rea IM, Alexander HD, Morris TC Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging. J Clin Immunol 1998; 18: 31-38.
23. Möller MJ, Kammerer R., von Kleist S. A distinct distribution of natural killer cell subgroups in human tissues and blood. Int J Cancer 1998; 78: 533-538.
24. Cavaillon J-M. Interleukine-1. In: Cavaillon J-M, ed. Les cytokines, 2nd edn. Paris: Masson 1996: 93-117.
25. Cavaillon J-M. Interleukine-6. In: Cavaillon J-M, ed. Les cytokines, 2nd edn. Paris: Masson 1996: 183-199.
26. De Maeyer-Guignard J. Interferons alpha et beta. In: Cavaillon J-M, ed. Les cytokines, 2nd edn. Paris: Masson 1996: 335-347.
27. Juretic A., Spagnoli GC, Von Bremen K.et al.Generation of lymphokine-activated killer activity in rodents but not in humans is nitric oxide-dependent Cell Immunol 1994; 157: 462-477.
28. Xiao L., Eneroth PHE, Quresh GA Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity. Scand J Immunol 1995; 42: 505-511.
29. Feinstein DL Potentiation of astroglial nitric oxide synthase type-2 expression by lithium chloride. J Neurochem 1998; 71: 883-886.
30. Schmidt RE, Murray C., Daley JF, Schlossman SF, Ritz J. A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med 1986; 164: 351-356.
31. Sugita M., Moody DB, Jackman RMet al.CD-1. A new paradigm for antigen presentation and T cell activation. Clin Immunol Immunopathol 1998; 87: 8-14.
32. Di Fabrizio L., Kimura Y., Ware R., Rogozinski L., Chess L. Specific triggering of γ, δ T cell by K562 activates the γ, δ T cell receptor and may regulate natural killer-like function. J Immunol 1991; 146: 2495-2503.